𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial

✍ Scribed by S. Hanauer; W. J. Sandborn; A. Persson; T. Persson


Book ID
108603964
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
185 KB
Volume
21
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sarizotan as a treatment for dyskinesias
✍ Christopher G. Goetz; Philippe Damier; Christine Hicking; Eugene Laska; Thomas M πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views

## Abstract The objective of this study is to conduct a dose‐finding study of sarizotan in Parkinson's disease (PD) patients with dyskinesia to identify a safe dose and to identify a sensitive dyskinesia rating measure. Sarizotan is a novel compound with full 5‐HT~1A~ agonist properties and additio

A randomized, double-blind, placebo-cont
✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 486 KB πŸ‘ 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des